Probiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model

Por Rather, Irfan A., Bajpai, Vivek K., Huh, Yun Suk, Han, Young-Kyu, Bhat, Eijaz A., Lim, Jeongheui, Paek, Woon K., Park, Yong-Ha
Publicado no Front Microbiol (2018)

GESTATIONAL MODIFICATION OF MURINE SPIRAL ARTERIES DOES NOT REDUCE THEIR DRUG-INDUCED VASOCONSTRICTIVE RESPONSES IN VIVO

Por Leonard, Sean, Lima, Patricia D.A., Croy, B. Anne, Murrant, Coral L.
Publicado em 2013

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

Por Pertwee, Roger G.
Publicado em 2005

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria

Por Charrier, Cédric, Salisbury, Anne-Marie, Savage, Victoria J., Duffy, Thomas, Moyo, Emmanuel, Chaffer-Malam, Nathan, Ooi, Nicola, Newman, Rebecca, Cheung, Jonathan, Metzger, Richard, McGarry, David, Pichowicz, Mark, Sigerson, Ralph, Cooper, Ian R., Nelson, Gary, Butler, Hayley S., Craighead, Mark, Ratcliffe, Andrew J., Best, Stuart A., Stokes, Neil R.
Publicado no Antimicrob Agents Chemother (2017)

In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens

Por César-Razquin, Adrián, Girardi, Enrico, Yang, Mi, Brehme, Marc, Saez-Rodriguez, Julio, Superti-Furga, Giulio
Publicado no Front Pharmacol (2018)

Elevated XIAP expression alone does not confer chemoresistance

Por Seeger, J M, Brinkmann, K, Yazdanpanah, B, Haubert, D, Pongratz, C, Coutelle, O, Krönke, M, Kashkar, H
Publicado em 2010

Analysis of pramipexole dose–response relationships in Parkinson’s disease

Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)

Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

Por Wattmo, Carina, Jedenius, Erik, Blennow, Kaj, Wallin, Åsa K
Publicado em 2013

Antibody format and drug release rate determine the therapeutic activity of non-internalizing antibody-drug conjugates

Por Gébleux, Rémy, Wulhfard, Sarah, Casi, Giulio, Neri, Dario
Publicado no Mol Cancer Ther (2015)

Public Health and International Drug Policy: Report of the Johns Hopkins – Lancet Commission on Drug Policy and Health

Por Csete, Joanne, Kamarulzaman, Adeeba, Kazatchkine, Michel, Altice, Frederick, Balicki, Marek, Buxton, Julia, Cepeda, Javier, Comfort, Megan, Goosby, Eric, Goulão, João, Hart, Carl, Horton, Richard, Kerr, Thomas, Lajous, Alejandro Madrazo, Lewis, Stephen, Martin, Natasha, Mejía, Daniel, Mathiesson, David, Obot, Isidore, Ogunrombi, Adeolu, Sherman, Susan, Stone, Jack, Vallath, Nandini, Vickerman, Peter, Zábranský, Tomáš, Beyrer, Chris
Publicado no Lancet (2016)

2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity

Por Lou, Bin, Liu, Qi, Hou, Jiahui, Kabir, Inamul, Liu, Peipei, Ding, Tingbo, Dong, Jibin, Mo, Mingguang, Ye, Deyong, Chen, Yang, Bui, Hai H., Roth, Kenneth, Cao, Yu, Jiang, Xian-Cheng
Publicado no J Biol Chem (2018)

Does Scale of Public Hospitals Affect Bargaining Power? Evidence From Japan

Por Noto, Konosuke, Kojo, Takao, Innami, Ichiro
Publicado no Int J Health Policy Manag (2017)

Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?

Por Brabers, Anne EM, Moors, Ellen HM, van Weely, Sonja, de Vrueh, Remco LA
Publicado em 2011

Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice

Por Grönholm, Juha, Pagni, Philippe P., Pham, Minh N., Gibson, Claire B., Macomber, Paul F., Vela, José Luis, von Herrath, Matthias, Lenardo, Michael J.
Publicado no Diabetologia (2017)

How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?

Por Sankaranarayanan, Rajiv, Kirkwood, Graeme, Visweswariah, Rajaverma, Fox, David J.
Publicado no Curr Cardiol Rev (2015)

Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial

Por Kosilov, Kirill Vladimirovich, Loparev, Sergey, Kuzina, Irina, Shakirova, Olga, Zhuravskaya, Nataliya, Lobodenko, Alexandra
Publicado no Ther Adv Urol (2016)

Athletic Trainers' Attitudes Toward Drug Screening of Intercollegiate Athletes

Por Starkey, Chad, Abdenour, Thomas E., Finnane, David
Publicado em 1994

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Por Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., Kearney, M. F., Proschan, M. A., Mican, J. M., Rehm, C. A., Coffin, J. M., Mellors, J. W., Siliciano, R. F., Maldarelli, F.
Publicado em 2009

Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia

Por Tiyou, Ayele, Belachew, Tefera, Alemseged, Fisehaye, Biadgilign, Sibhatu
Publicado em 2010

Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon

Por Djobet, M. P. Ngogang, Singhe, David, Lohoue, Julienne, Kuaban, Christopher, Ngogang, Jeanne, Tambo, Ernest
Publicado no AIDS Res Ther (2017)